• The depression module of the Schedule for the Clinical Assessment in Neuropsychiatry (SCAN) 13 to diagnose depression. Recorded data were entered into a computer algorithm that generated a diagnosis according to the The SCAN and the BDI were translated into pidgin English, which is the lingua franca in the cosmopolitan city of Benin, using the method of back translation. One of the authors administered the questionnaires to respondents to aid consistency.
Ethics
The ethics review committee of UBTH reviewed and approved the study protocol.
Procedure
Patients attending scheduled clinic visits, who satisfied the inclusion criteria, were approached by one of the authors. 
Data analysis
Data were analysed using the Statistics for Social Science (SPSS) software, version 11. Descriptive statistics were used to summarise the data. Comparisons of categorical and continuous variables were done using the chi-square and t-tests respectively.
Relationships between continuous variables were conducted using the Pearson correlation analyses.
Results
Over the study period, 211 patients satisfied the study's inclusion criteria and were approached, of whom 200 consented to participate in the study (94% participation rate In the index group, a majority were being managed for type 2 DM, and most (69%) reported having other physical co-morbidities. The most common (68.5%) were cardiovascular (hypertension, ischaemic heart disease and cerebrovascular incidents however, this association was not significantly correlated (Table   II) .
Discussion
The prevalence of depression (30%) among patients with DM in this study using a diagnostic instrument, was much higher than that reported in an earlier study (9.5%) conducted in this environment and employing similar methodology. 3 Although the mean age of the population in the study by Issa et al. 3 was similar to that in our study, our sample had a higher representation of reporting having other physical co-morbidities may account for this. Furthermore, the prevalence of depression symptoms using a cut-off score of 10 and above on the BDI was 39.5%, which was also higher than the range of 20 -31% observed in other studies in the country employing the use of rating scales alone. [10] [11] [12] We found a significant correlation between earning power, having more children and depression symptom severity as measured by the BDI. DM is a chronic physical disorder that requires lifestyle alterations and medication adherence for its successful treatment.
Individuals with low earning power face the twin burdens of paying for health care, which in Nigeria is largely out-of-pocket, and meeting the needs of their children. Our study design does not permit interpretations as to causality or the temporal relationships between depression, low earning power and larger number of children; however, it may be safe to say that the presence of these characteristics in persons with diabetes could be a pointer to the presence of depressive symptoms, especially in individuals with poor glycaemic control and medication adherence.
Although diabetes patients who were female, married, or had less than 12 years of education were more likely to have a SCAN diagnosis of depression, we found no statistically significant associations. Our finding contrasts the report from Texas, USA, where female gender and a lower duration of formal education were predictors of depression. 7 Our study is not without limitations. Firstly, it was conducted at one centre, which limits the generalisation of our findings. Secondly, we did not control for other mental illnesses such as anxiety disorder which are co-morbid with depression in DM. Thirdly, we did not determine the validity of the translated questionnaires as well as the reliability of the self-or interviewer-administered forms.
Conclusion
DM is expected to assume pandemic proportions in sub-Saharan Africa. 10 Our study further confirms the impression that depression is highly co-morbid with the disease. The negative effect of depression on achieving good glycaemic control means that physicians need to screen for and manage this disorder to improve not only the quality of life of diabetes patients but also reduce overall treatment costs, which are generally unaffordable by most individuals with the disease.
